Home/NexImmune/John M. (Jerry) Cacciutti
JM

John M. (Jerry) Cacciutti

Chief Financial Officer

NexImmune

NexImmune Pipeline

DrugIndicationPhase
NEXI-001Acute Myeloid Leukemia (post-allo SCT)Phase 1/2
NEXI-002Multiple Myeloma (post-auto SCT)Phase 1/2
NEXI-003HPV-16+ Solid TumorsPhase 1/2